Home › Free Stock Grades › STRO
Sutro Biopharma, Inc. (STRO) Stock Grade
STRO · Healthcare
C
Market Cap
$155.1M
P/E Ratio
—
Revenue Growth (YoY)
+65.2%
Net Margin
-186.5%
Return on Equity
144.3%
Dividend Yield
None
About Sutro Biopharma, Inc.'s fundamentals
Sutro Biopharma is a small-cap biotechnology company with a market capitalization of $155.1 million that reported strong revenue growth of 65.2% year-over-year, indicating expanding business activity. However, the company is currently unprofitable with a net margin of -186.5% and reported a net loss in its latest annual statement, meaning it is spending significantly more than it generates in revenue. The company does not pay a dividend, which is typical for early-stage biotech firms reinvesting losses into operations and research and development.